The 30s would have been nice, but it hasn't really come back since the stock recommendation from a service which also prompted an ASX letter.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025